EGFR and KRAS mutations in Chinese patients with sinonasal inverted papilloma and oncocytic papilloma.


Journal

Histopathology
ISSN: 1365-2559
Titre abrégé: Histopathology
Pays: England
ID NLM: 7704136

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 13 11 2018
accepted: 23 03 2019
pubmed: 28 3 2019
medline: 21 1 2020
entrez: 28 3 2019
Statut: ppublish

Résumé

Sinonasal inverted papilloma (SIP) and sinonasal oncocytic papilloma (SOP) are uncommon, benign epithelial neoplasms located in the sinonasal region, that have the potential for malignant transformation. A recent study reported that EGFR and KRAS mutations occurred in the majority of Western patients with SIP and SOP, respectively. The aims of this study were to investigate the prevalence of KRAS and EGFR mutations in Chinese SIP and SOP patients, and to study the association between molecular alterations and their clinical features. We retrospectively collected 80 sinonasal papilloma specimens, including 44 cases with SIP, 33 cases with SOP, and three cases with mixed sinonasal papilloma, which harboured elements of both inverted and oncocytic types. Formalin-fixed paraffin-embedded tissues were used to extract genomic DNA, and EGFR and KRAS mutations were evaluated with direct Sanger sequencing. Thirty-five (78%) SIP patients harboured EGFR mutations, and all mutations were exon 20 insertions, whereas no KRAS mutations were detected. In contrast, KRAS mutations were detected in 82% of SOP patients, but no EGFR mutations were detected. Among the three mixed-type cases, two harboured both EGFR exon 20 insertions and KRAS mutations. Another case harboured a KRAS mutation, but no EGFR mutation was detected. SIP and SOP are two clinical entities with different genetic mutational patterns of EGFR and KRAS. Mixed types with elements of both SIP and SOP may harbour both EGFR and KRAS mutations.

Identifiants

pubmed: 30916792
doi: 10.1111/his.13868
doi:

Substances chimiques

KRAS protein, human 0
EGFR protein, human EC 2.7.10.1
ErbB Receptors EC 2.7.10.1
Proto-Oncogene Proteins p21(ras) EC 3.6.5.2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

274-281

Subventions

Organisme : Natural Science Foundation of China
ID : 81371077
Organisme : Natural Science Foundation of Shanghai
ID : 16ZR1405000
Organisme : Youth Sailing Programme of Excellence in Science and Technology
ID : 15YF1401900

Informations de copyright

© 2019 John Wiley & Sons Ltd.

Auteurs

Huan Wang (H)

Department of Otolaryngology, Eye, Ear, Nose and Throat Hospital, Shanghai, China.

Hongbing Li (H)

Department of Otolaryngology, Eye, Ear, Nose and Throat Hospital, Shanghai, China.

Li Hu (L)

Department of Otolaryngology, Eye, Ear, Nose and Throat Hospital, Shanghai, China.

Jiaying Zhou (J)

Department of Otolaryngology, Eye, Ear, Nose and Throat Hospital, Shanghai, China.

Changwen Zhai (C)

Department of Pathology, Eye, Ear, Nose and Throat Hospital, Fudan University, Shanghai, China.

Dehui Wang (D)

Department of Otolaryngology, Eye, Ear, Nose and Throat Hospital, Shanghai, China.

Xicai Sun (X)

Department of Otolaryngology, Eye, Ear, Nose and Throat Hospital, Shanghai, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH